A detailed history of Bartlett & Co. Wealth Management LLC transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Bartlett & Co. Wealth Management LLC holds 250 shares of ICCM stock, worth $212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$212
Previous $185,000 17.3%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$1.16 - $1.48 $290 - $370
250 New
250 $300,000
Q3 2023

Feb 14, 2024

SELL
$0.54 - $1.33 $135 - $332
-250 Closed
0 $0
Q1 2022

Feb 14, 2024

BUY
$2.01 - $3.31 $502 - $827
250 New
250 $607,000

Others Institutions Holding ICCM

About IceCure Medical Ltd.


  • Ticker ICCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,835,600
  • Market Cap $31.3M
  • Description
  • IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
More about ICCM
Track This Portfolio

Track Bartlett & Co. Wealth Management LLC Portfolio

Follow Bartlett & Co. Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.